Skip to main content

Table 2 Endpoint breadth used for different drug management tool categories

From: Systematic review on quality control for drug management programs: Is quality reported in the literature?

Number of Endpoints

1

2

3

4

5

Number of Studies

Average No. of Endpoints

St. Dev

Drug Management Tool Category

        

Financial responsibility to patient

16

8

13

4

2

43

2.3

1.2

Limit access to non-preferred agents

17

12

8

2

1

40

2.0

1.0

Stimulate switch to preferred agents

6

2

0

0

0

8

1.3

0.5

All Drug Management Programs

29

20

18

6

3

 

2.1

1.1

  1. Analysis by number of endpoints included in the studies in each drug management tool category (n = 76)